SuperGenerics: A better alternative for biogenerics

Drug Discovery Today

Volumn 10, Issue 8, 2005, Pages 533-535

  Charles, Stephen A ^a  

^a NEKTAR THERAPEUTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG; INSULIN; PEGINTERFERON ALPHA2A; RECOMBINANT ERYTHROPOIETIN;

DRUG COST; DRUG INDUSTRY; DRUG MARKETING; EDITORIAL; HUMAN;

BIOLOGICAL PRODUCTS; DRUG APPROVAL; DRUG INDUSTRY; DRUGS, GENERIC; HUMANS; PATENTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 17444374955     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(05)03410-0     Document Type: Editorial

References (11)

1. Class S. Biogenerics: waiting for the green light. IMS Health. 2004
2. Heathcote E.J., et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N. Engl. J. Med. 342:2000;1673-1680
3. Zeuzem S., et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N. Engl. J. Med. 343:2000;166-1672
4. st Scientific Sessions, Friday, June 22 - Tuesday, June 26, 2001.
5. Cefalu W.T., et al. Inhaled Human Insulin Treatment in Patients with Type 2 Diabetes Mellitus. Annals of Internal Medicine. 134:2001;203-207
6. Cefalu W.T. et al (2000) Sustained Efficacy and Pulmonary Safety of Inhaled Insulin During 2-years of Outpatient Therapy. Diabetes: Abstract Book, 60th Scientific Sessions, Friday, June 9 - Tuesday, June 13, 2000, p. A101.
7. Skyler J.S., et al. Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomized proof-of-concept study. Lancet. 357:2001;331-335
8. Rosenstock, J. (2002) for the Exubera® Phase III study Group. Mealtime Rapid-Acting Inhaled Insulin (Exubera®) Improves Glycemic Control in Patients with Type 2 Diabetes Failing combination Oral Agents: A 3-month, Randomized, Comparative Trial. Diabetes: Abstract Book, 62nd Scientific Sessions (American Diabetes Association), Friday, June 14 - Tuesday. June 18 2001, A132.
9. Su, M. et al (2002) The Relationship between Regimen Burden and Psychological Well Being in Persons with Type I Diabetes: Inhaled vs. Injectable Insulin. Diabetes: Abstract Book, 62nd Scientific Sessions (American Diabetes Association), Friday, June 14-Tuesday, June 18, 2002. p. A448.
10. Cappeleri, J.C. et al (2001) Relationship Between Improved Patient Satisfaction and Improved Glycemic Control in Patients with Type 1 and Type 2 Diabetes Mellitus Treated with Inhaled Insulin: Pooled Results from Two Multicenter Randomized Controlled Trials. Diabetes: Abstract Book, 61st Scientific Sessions, Friday, June 22 - Tuesday, June 26, 2001. p. A108.
11. Simonson, D.C. et al (2001) Treatment satisfaction and preferences in Type 2 Diabetes: A randomized trial of oral agents vs. inhaled insulin. 3-month study included: patients on oral agents only; patients on both inhaled and oral agents; patients on inhaled insulin only (monotherapy). Diabetes: Abstract Book, 61st Scientific Sessions, Friday, June 22 - Tuesday, June 26, 2001. p. A131.